Alexander M. Aravanis - Publications

Affiliations: 
2005 Stanford University, Palo Alto, CA 

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Bredno J, Lipson J, Venn O, Gross S, Fields AP, Beausang JF, Liu Q, Brooks JD, Chen X, Lopatin R, Liu H, Zhang N, Zhang L, Wu T, Allen B, ... ... Aravanis A, et al. Tumor area and microscopic extent of invasion to determine circulating tumor DNA fraction in plasma and detectability of colorectal cancer (CRC). Journal of Clinical Oncology. 38: 243-243. DOI: 10.1200/Jco.2020.38.4_Suppl.243  0.311
2020 Hartman A, Oxnard G, Klein E, Seiden M, Hubbell E, Venn O, Jamshidi A, Zhang N, Beausang J, Gross S, Kurtzman K, Fung E, Allen B, Fields A, Liu H, ... ... Aravanis A, et al. Abstract IA02: Multicancer detection of early-stage cancers with simultaneous tissue localization using a plasma cfDNA-based targeted methylation assay Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Liqbiop20-Ia02  0.334
2020 Bredno J, Gross S, Fields AP, Kurtzman KN, Shaknovich R, Yecies J, Chen X, Schellenberger J, Scott E, Dong Z, Fung ET, Hartman A, Hubbell E, Jamshidi A, Aravanis AM, et al. Abstract 2308: Classifier performance of a cfDNA-based multi-cancer detection test on uncommon cancer types Cancer Research. 80: 2308-2308. DOI: 10.1158/1538-7445.Am2020-2308  0.315
2020 Liu Q, Shaknovich R, Chen X, Dong Z, Maher MC, Gross S, Fields AP, Schellenberger J, Kurtzman KN, Fung ET, Hartman A, Hubbell E, Jamshidi A, Aravanis AM, Venn O. Abstract 139: cfDNA methylation profiling distinguishes lineage-specific hematologic malignancies Cancer Research. 80: 139-139. DOI: 10.1158/1538-7445.Am2020-139  0.306
2020 Kurtzman KN, Oxnard G, Klein E, Seiden M, Hubbell E, Venn O, Jamshidi A, Zhang N, Beausang J, Gross S, Hartman A, Fung E, Allen B, Fields AP, Liu H, ... ... Aravanis A, et al. Su1772 MULTI-CANCER DETECTION OF EARLY-STAGE CANCERS WITH SIMULTANEOUS TISSUE LOCALIZATION USING A PLASMA CIRCULATING TUMOR CELL-FREE DNA-BASED TARGETED METHYLATION ASSAY Gastroenterology. 158: S-642. DOI: 10.1016/S0016-5085(20)32300-3  0.319
2020 Liu M, Oxnard G, Klein E, Swanton C, Seiden M, Cummings SR, Absalan F, Alexander G, Allen B, Amini H, Aravanis AM, Bagaria S, Bazargan L, Beausang JF, Berman J, et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA Annals of Oncology. 31: 745-759. DOI: 10.1016/J.Annonc.2020.02.011  0.302
2019 Li BT, Janku F, Jung B, Hou C, Madwani K, Alden R, Razavi P, Reis-Filho JS, Shen R, Isbell JM, Blocker AW, Eattock N, Gnerre S, Satya RV, Xu H, ... ... Aravanis A, et al. Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 30891595 DOI: 10.1093/Annonc/Mdz046  0.304
2019 Oxnard GR, Klein EA, Seiden M, Hubbell E, Venn O, Jamshidi A, Zhang N, Beausang JF, Gross S, Kurtzman KN, Fung ET, Yecies J, Shaknovich R, Fields AP, Sekeres MA, ... ... Aravanis A, et al. Simultaneous multi-cancer detection and tissue of origin (TOO) localization using targeted bisulfite sequencing of plasma cell-free DNA (cfDNA). Journal of Global Oncology. 5: 44-44. DOI: 10.1200/Jgo.2019.5.Suppl.44  0.333
2019 Liu MC, Jamshidi A, Venn O, Fields AP, Maher MC, Cann G, Amini H, Gross S, Bredno J, Miller M, Schellenberger J, Kurtzman KN, Fung ET, Maddala T, Oxnard GR, ... ... Aravanis A, et al. Genome-wide cell-free DNA (cfDNA) methylation signatures and effect on tissue of origin (TOO) performance. Journal of Clinical Oncology. 37: 3049-3049. DOI: 10.1200/Jco.2019.37.15_Suppl.3049  0.314
2019 Oxnard GR, Chen X, Fung ET, Ma T, Lipson J, Hubbell E, Kurtzman KN, Patel S, Shaknovich R, Dong Z, Liu H, Brooks JD, Spigel DR, Seiden M, Aravanis A, et al. Prognostic significance of blood-based cancer detection in plasma cell-free DNA (cfDNA): Evaluating risk of overdiagnosis. Journal of Clinical Oncology. 37: 1545-1545. DOI: 10.1200/Jco.2019.37.15_Suppl.1545  0.316
2019 Oxnard G, Klein E, Seiden M, Hubbell E, Venn O, Jamshidi A, Zhang N, Beausang J, Gross S, Kurtzman K, Fung E, Allen B, Fields A, Liu H, Sekeres M, ... ... Aravanis A, et al. Simultaneous multi-cancer detection and tissue of origin (TOO) localization using targeted bisulfite sequencing of plasma cell-free DNA (cfDNA) Annals of Oncology. 30: v912. DOI: 10.1093/Annonc/Mdz394.074  0.316
2018 Oxnard GR, Maddala T, Hubbell E, Aravanis A, Zhang N, Venn O, Valouev A, Shen L, Patel S, Jamshidi A, Jagadeesh K, Gross S, Filippova D, Beausang JF, Liu MC, et al. Genome-wide sequencing for early stage lung cancer detection from plasma cell-free DNA (cfDNA): The Circulating Cancer Genome Atlas (CCGA) study. Journal of Clinical Oncology. 36: LBA8501-LBA8501. DOI: 10.1200/Jco.2018.36.18_Suppl.Lba8501  0.303
2018 Klein EA, Hubbell E, Maddala T, Aravanis A, Beausang JF, Filippova D, Gross S, Jamshidi A, Kurtzman K, Shen L, Valouev A, Venn O, Zhang N, Smith DA, Yeatman TJ, et al. Development of a comprehensive cell-free DNA (cfDNA) assay for early detection of multiple tumor types: The Circulating Cell-free Genome Atlas (CCGA) study. Journal of Clinical Oncology. 36: 12021-12021. DOI: 10.1200/Jco.2018.36.15_Suppl.12021  0.322
2018 Liu M, Klein E, Hubbell E, Maddala T, Aravanis A, Beausang J, Filippova D, Gross S, Jamshidi A, Kurtzman K, Shen L, Zhang N, Venn O, Yecies J, Patel S, et al. Plasma cell-free DNA (cfDNA) assays for early multi-cancer detection: The circulating cell-free genome atlas (CCGA) study Annals of Oncology. 29: viii14. DOI: 10.1093/Annonc/Mdy269.048  0.314
2016 Li BT, Janku F, Janne PA, Mills GB, Madwani K, Alden RS, Paweletz CP, Ladanyi M, Aravanis A, Jung B, Gnerre S, Sehnert AJ, Solit DB, Riely GJ, Oxnard GR. Abstract 4342: Ultra-deep next generation sequencing (NGS) of plasma cell-free DNA (cfDNA) from patients with advanced lung cancers: results from the Actionable Genome Consortium Cancer Research. 76: 4342-4342. DOI: 10.1158/1538-7445.Am2016-4342  0.314
2011 Stroh A, Tsai HC, Wang LP, Zhang F, Kressel J, Aravanis A, Santhanam N, Deisseroth K, Konnerth A, Schneider MB. Tracking stem cell differentiation in the setting of automated optogenetic stimulation. Stem Cells (Dayton, Ohio). 29: 78-88. PMID 21280159 DOI: 10.1002/Stem.558  0.495
2007 Adamantidis AR, Zhang F, Aravanis AM, Deisseroth K, de Lecea L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature. 450: 420-4. PMID 17943086 DOI: 10.1038/Nature06310  0.445
2007 Aravanis AM, Wang LP, Zhang F, Meltzer LA, Mogri MZ, Schneider MB, Deisseroth K. An optical neural interface: in vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technology. Journal of Neural Engineering. 4: S143-56. PMID 17873414 DOI: 10.1088/1741-2560/4/3/S02  0.476
2007 Zhang F, Aravanis AM, Adamantidis A, de Lecea L, Deisseroth K. Circuit-breakers: optical technologies for probing neural signals and systems. Nature Reviews. Neuroscience. 8: 577-81. PMID 17643087 DOI: 10.1038/nrn2192  0.374
2006 Harata NC, Aravanis AM, Tsien RW. Kiss-and-run and full-collapse fusion as modes of exo-endocytosis in neurosecretion. Journal of Neurochemistry. 97: 1546-70. PMID 16805768 DOI: 10.1111/J.1471-4159.2006.03987.X  0.734
2006 Harata NC, Choi S, Pyle JL, Aravanis AM, Tsien RW. Frequency-dependent kinetics and prevalence of kiss-and-run and reuse at hippocampal synapses studied with novel quenching methods. Neuron. 49: 243-56. PMID 16423698 DOI: 10.1016/J.Neuron.2005.12.018  0.693
2003 Aravanis AM, Pyle JL, Harata NC, Tsien RW. Imaging single synaptic vesicles undergoing repeated fusion events: kissing, running, and kissing again. Neuropharmacology. 45: 797-813. PMID 14529718 DOI: 10.1016/S0028-3908(03)00310-1  0.746
2003 Aravanis AM, Pyle JL, Tsien RW. Single synaptic vesicles fusing transiently and successively without loss of identity. Nature. 423: 643-7. PMID 12789339 DOI: 10.1038/Nature01686  0.764
2001 Harata N, Pyle JL, Aravanis AM, Mozhayeva M, Kavalali ET, Tsien RW. Limited numbers of recycling vesicles in small CNS nerve terminals: implications for neural signaling and vesicular cycling. Trends in Neurosciences. 24: 637-43. PMID 11672807 DOI: 10.1016/S0166-2236(00)02030-0  0.713
Show low-probability matches.